ApprovalTrail

Drug · DIN 02566680

ADSTILADRIN

SINGLE-USE VIALS

Authorized, not yet reported as sold

Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.

Status Approved since March 16, 2026.
Drug Identification Number (DIN)
02566680
Company (DIN owner)
Ferring Inc.North York, Ontario, Canada
Schedule
Schedule D; Prescription
Dosage form
Suspension
Route
Intravesical
Therapeutic class (ATC)
Nadofaragene firadenovec L01XL10
Class
Human
Record last updated
August 10, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
NADOFARAGENE FIRADENOVEC300000000000 VPML

Notices of Compliance

Health Canada approvals that name this DIN.